FDA adds rare vision-loss warning to popular GLP-1 drugs
3 left · 2 center · 2 right
Reached 1% of the left-leaning outlets we follow, under 1% of center and 1% of right-leaning. Why this matters
How each side headlined it
Left-leaning 3
Only this side used: regulatorinformed4esttfkhealth
Center 2
Only this side used: administrationpharmaceuticalnon-arteriticneuropathy
Right-leaning 2
Only this side used: requiringpermanentincurableblindness
Unrated, estimated and state media 8
Not counted on either side. Why
